NCT05571839 2026-03-13A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid TumorsSeagen Inc.Phase 1 Active not recruiting41 enrolled
NCT05873686 2026-03-03A Phase 1 Clinical Study of NXP900 in Subjects With Advanced CancersNuvectis Pharma, Inc.Phase 1 Recruiting140 enrolled
NCT06885697 2026-02-17Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including MesotheliomaNational Institutes of Health Clinical Center (CC)Phase 1 Recruiting100 enrolled
NCT04166734 2026-02-04MESO-PRIMERoyal Marsden NHS Foundation TrustPhase 1 Terminated5 enrolled 13 charts
NCT07277413 2026-01-20A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsIDEAYA BiosciencesPhase 1 Recruiting260 enrolled
NCT06466187 2026-01-12A Study of SGN-MesoC2 in Advanced Solid TumorsSeagen Inc.Phase 1 Active not recruiting19 enrolled
NCT05544929 2026-01-06A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced CancersNovartisPhase 1 Active not recruiting126 enrolled